<DOC>
	<DOC>NCT00985166</DOC>
	<brief_summary>The study was conducted to determine if ProQuad may be used in place of the second dose of M-M-R II routinely given to children 4 to 6 years old who were previously immunized with M-M-R II and Varivax.</brief_summary>
	<brief_title>A Study of ProQuad in Healthy 4 to 6 Year Old Children (V221-014)</brief_title>
	<detailed_description />
	<mesh_term>Measles</mesh_term>
	<mesh_term>Rubella</mesh_term>
	<mesh_term>Chickenpox</mesh_term>
	<mesh_term>Herpes Zoster</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>In good health Received primary dose of MMR II at less than or equal to 12 months of age Received primary dose of Varivax at less than or equal to 12 months of age Negative history of varicella, zoster, measles, mumps, and rubella history of receiving more than once dose of MMR II or Varivax Any immune impairment or deficiency Exposure to measles, mumps, rubella, varicella, or zoster in the 4 weeks prior to vaccination Vaccination with an inactive vaccine with in the past 14 days Vaccination with a live vaccine within the past 30 days Receipt of immune globulin, or blood product in the past 5 months</criteria>
	<gender>All</gender>
	<minimum_age>4 Years</minimum_age>
	<maximum_age>6 Years</maximum_age>
	<verification_date>July 2015</verification_date>
</DOC>